Fate Therapeutics Inc (NASDAQ: FATE) Just Learned Something New After This Week’s -1.21% Loss
Fate Therapeutics Inc (NASDAQ:FATE)’s traded shares stood at 2.72 million during the last session, with the company’s beta value hitting 1.66. At the close of